Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

46.84
+0.17000.36%
Post-market: 46.850.0081+0.02%19:59 EDT
Volume:17.15M
Turnover:802.65M
Market Cap:67.88B
PE:18.98
High:47.22
Open:46.85
Low:46.50
Close:46.67
52wk High:109.50
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.67
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.72
PE(LYR):24.14

Loading ...

Boston Scientific Exec Says Co Expects 2027 Watchman Trends to Improve from H2 2026 Levels

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co NOW Expects Global Watchman Sales Growth to be Flat to Low Single Digits in 2026

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Second Half Watchman Revenue is Expected to Decline at a Mid- to High-Single-Digit Rate Year over Year

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co NOW Expects H2 2026 to be More "Pressured" than Originally Anticipated - Conf Call

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co Expect EPS and Revenue Growth to Improve Meaningfully in 2028

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Updated Forecast Reflects a "Realistic View" of H2 2026

THOMSON REUTERS
·
Jul 29

U.S. Stocks on the MOVE-Seagate, Bloom Energy, Generac

Reuters
·
Jul 29

Boston Scientific Shares up 3.7% Premarket After Q2 Results Beat

THOMSON REUTERS
·
Jul 29

Boston Scientific Rises After Quarterly Results Beat Estimates

Reuters
·
Jul 29

Boston Scientific Logs Higher 2Q, Cuts Outlook Ahead of Restructuring

Dow Jones
·
Jul 29

Boston Scientific Trims Annual Profit Forecast on Softer Watchman Device Demand

Reuters
·
Jul 29

Ceribell Names Thomas West, Sharon O’Keefe to Board of Directors

Reuters
·
Jul 29

Stock Track | Boston Scientific Soars 6.32% in Pre-Market on Q2 Earnings Beat

Stock Track
·
Jul 29

Boston Scientific Q2 Adjusted Earnings, Revenue Rise; Lowers 2026 Guidance

MT Newswires Live
·
Jul 29

Boston Scientific Q2 Results Beat Estimates on Cardiovascular Strength

Reuters
·
Jul 29

GUIDANCE: (BSX) Boston Scientific Expects 2026 Adjusted EPS Range $3.28 to $3.32, vs. FactSet Est of $3.36

MT Newswires Live
·
Jul 29

Boston Scientific Q2 Adj. EPS $0.86 Beats $0.83 Estimate, Sales $5.442B Beat $5.361B Estimate

Benzinga Earnings
·
Jul 29

Boston Scientific Corp Outlook Q3 Adj EPS $0.80 to $0.82

THOMSON REUTERS
·
Jul 29

Boston Scientific Q2 EPS USD 0.61

THOMSON REUTERS
·
Jul 29

Boston Scientific: Estimates Net Sales Growth for Q3 of 2026, to be About 3 to 5 Percent on Reported and Organic Basis

THOMSON REUTERS
·
Jul 29